(Q48187532)

English

Prognostic impact of minimal disseminated disease and immune response to NPM-ALK in Japanese children with ALK-positive anaplastic large cell lymphoma.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29030834%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Prognostic impact of minimal disseminated disease and immune response to NPM-ALK in Japanese children with ALK-positive anaplastic large cell lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29030834%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Yuka Iijima-Yamashita

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29030834%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

author name string

Tetsuya Mori

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29030834%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Atsuko Nakazawa

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29030834%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Reiji Fukano

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29030834%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Tetsuya Takimoto

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29030834%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Masahito Tsurusawa

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29030834%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Ryoji Kobayashi

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29030834%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Keizo Horibe

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29030834%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

publication date

13 October 2017

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29030834%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

International Journal of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29030834%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

107

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29030834%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29030834%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

244-250

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29030834%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Impact of the methotrexate administration dose on the need for intrathecal treatment in children and adolescents with anaplastic large-cell lymphoma: results of a randomized trial of the EICNHL Group

1 reference

https://api.crossref.org/works/10.1007%2FS12185-017-2338-6

21 January 2018

Vinblastine in children and adolescents with high-risk anaplastic large-cell lymphoma: results of the randomized ALCL99-vinblastine trial

1 reference

https://api.crossref.org/works/10.1007%2FS12185-017-2338-6

21 January 2018

Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies

1 reference

https://api.crossref.org/works/10.1007%2FS12185-017-2338-6

21 January 2018

Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-017-2338-6

21 January 2018

Anaplastic large cell lymphoma in childhood: analysis of 72 patients treated on The United Kingdom Children's Cancer Study Group chemotherapy regimens

1 reference

https://api.crossref.org/works/10.1007%2FS12185-017-2338-6

21 January 2018

Anaplastic large cell lymphoma treated with a leukemia-like therapy: report of the Italian Association of Pediatric Hematology and Oncology (AIEOP) LNH-92 protocol

1 reference

https://api.crossref.org/works/10.1007%2FS12185-017-2338-6

21 January 2018

Advanced-stage large-cell lymphoma in children and adolescents: results of a randomized trial incorporating intermediate-dose methotrexate and high-dose cytarabine in the maintenance phase of the APO regimen: a Pediatric Oncology Group phase III tri

1 reference

https://api.crossref.org/works/10.1007%2FS12185-017-2338-6

21 January 2018

Anaplastic large cell lymphoma in Japanese children: retrospective analysis of 34 patients diagnosed at the National Research Institute for Child Health and Development

1 reference

https://api.crossref.org/works/10.1007%2FS12185-017-2338-6

21 January 2018

Prognostic factors in childhood anaplastic large cell lymphoma: results of a large European intergroup study

1 reference

https://api.crossref.org/works/10.1007%2FS12185-017-2338-6

21 January 2018

Prognostic impact of morphologic and phenotypic features of childhood ALK-positive anaplastic large-cell lymphoma: results of the ALCL99 study

1 reference

https://api.crossref.org/works/10.1007%2FS12185-017-2338-6

21 January 2018

Use of minimal disseminated disease and immunity to NPM-ALK antigen to stratify ALK-positive ALCL patients with different prognosis.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-017-2338-6

21 January 2018

Immune response to the ALK oncogenic tyrosine kinase in patients with anaplastic large-cell lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/29030834

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence and clinical implications of bone marrow involvement in pediatric anaplastic large cell lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/29030834

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of circulating tumor cells in bone marrow or peripheral blood as detected by qualitative and quantitative PCR in pediatric NPM-ALK-positive anaplastic large-cell lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/29030834

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of Japanese registration from the randomized international trial for childhood anaplastic large cell lymphoma (ALCL99-R1)

1 reference

https://pubmed.ncbi.nlm.nih.gov/29030834

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of the autoantibody response to the ALK oncoantigen in pediatric anaplastic lymphoma kinase–positive anaplastic large cell lymphoma with tumor dissemination and relapse risk

1 reference

https://pubmed.ncbi.nlm.nih.gov/29030834

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD30(+) anaplastic large-cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology

1 reference

https://pubmed.ncbi.nlm.nih.gov/29030834

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Kinetics of humoral response to ALK and its relationship with minimal residual disease in pediatric ALCL

1 reference

https://pubmed.ncbi.nlm.nih.gov/29030834

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12185-017-2338-6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29030834%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29030834%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48187532&oldid=2209197340"